Regeneron Pharmaceuticals and Sonoma Biotherapeutics announced a collaboration to apply their scientific and clinical expertise and respective technology platforms to the discovery, development and commercialisation of novel regulatory T cell (Treg) therapies for autoimmune diseases. The collaboration will bring together Regeneron
